Date published: 2025-12-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

Claspin Inhibitors

Chemicals that serve as Claspin inhibitors typically fall into broader categories of kinase inhibitors or DNA damage response (DDR) modulators. They are compounds that interfere with the key signaling pathways and checkpoint controls within the cell cycle, particularly those related to replication stress and the activation of checkpoint kinases. The DDR pathway is a complex network of proteins that detect and repair DNA damage; within this network, Claspin plays a critical role as a mediator. Chemicals that inhibit the function of Claspin do so by targeting either the proteins that regulate Claspin's activity or the proteins that are regulated by Claspin. For instance, inhibitors of ATR kinase can prevent the phosphorylation and activation of Claspin, thereby preventing it from fulfilling its role in the activation of Chk1 during the DNA damage response. On the other hand, Chk1 inhibitors can make the role of Claspin redundant as Claspin is primarily involved in the activation of Chk1. These inhibitors can belong to various chemical classes, including but not limited to, staurosporines (a class of potent kinase inhibitors), pyrazinecarboxamides, indolocarbazoles, and benzimidazole carboxamides. The study of Claspin inhibitors is an area rooted in the fundamental understanding of cell cycle control mechanisms. The inhibitors mentioned are integral to research that elucidates the molecular intricacies of cell cycle checkpoints and DNA repair processes. They are essential tools in the dissection of the complex cellular events that orchestrate the response to DNA damage and replication stress.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

VE 821

1232410-49-9sc-475878
10 mg
$360.00
(0)

Selective ATR inhibitor, could reduce Claspins role in checkpoint signaling by reducing ATR-mediated phosphorylation.

SCH 900776

891494-63-6sc-364611
sc-364611A
5 mg
10 mg
$255.00
$338.00
(0)

Chk1 inhibitor, could decrease the need for Claspin as Chk1 is a downstream target of the Claspin-mediated signaling pathway.

UCN-01

112953-11-4sc-202376
500 µg
$246.00
10
(1)

Inhibits Chk1, potentially diminishing the function of Claspin in checkpoint activation.

AZD7762

860352-01-8sc-364423
2 mg
$107.00
(1)

Chk1 inhibitor, could bypass Claspins mediation by directly inhibiting its downstream effector.

LY2603618

911222-45-2sc-364526
sc-364526A
5 mg
50 mg
$214.00
$1809.00
(1)

Selective Chk1 inhibitor, might reduce the functional role of Claspin in DDR by targeting its partner kinase.

PF 477736

952021-60-2sc-362781
sc-362781A
5 mg
25 mg
$113.00
$423.00
(1)

ATR inhibitor, potentially affects Claspins activation role by inhibiting upstream kinase ATR.

Debromohymenialdisine

75593-17-8sc-202127
100 µg
$100.00
2
(1)

Inhibits checkpoint kinases including Chk1; this could reduce Claspins significance in checkpoint control.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor that also affects DNA-PK and ATR, potentially interfering with Claspin-related pathways.

ATM Kinase Inhibitor

587871-26-9sc-202963
2 mg
$108.00
28
(2)

ATM inhibitor, although not directly linked to Claspin, ATM inhibition can influence the overall DNA damage response network where Claspin operates.

NU 7441

503468-95-9sc-208107
5 mg
$350.00
10
(2)

DNA-PK inhibitor, potentially affecting the DNA damage response wherein Claspin has a regulatory role.